<DOC>
	<DOC>NCT01184417</DOC>
	<brief_summary>Intravenous phenobarbital in combination with a symptom-guided standardized lorazepam-based alcohol withdrawal protocol will be associated with decreased need for ICU admission, continuous lorazepam infusion and will not be associated with increased adverse events.</brief_summary>
	<brief_title>Phenobarbital for Acute Alcohol Withdrawal</brief_title>
	<detailed_description />
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>Need for admission to hospital for acute alcohol withdrawal allergy to phenobarbital, lorazepam, age&lt;18 or &gt;65</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>